Transplant News and Research

RSS

Burkitt lymphoma risk after transplantation highlighted

Solid organ transplant recipients have a significant risk for developing Burkitt lymphoma (BL), US researchers have found.

12 Feb 2013

Donor liver quality: an interview with Dr Eric Orman

Liver transplantation is a surgical procedure in which a liver (or part of a liver) is removed from a donor and placed into a recipient. Although some transplants use a portion of the liver of living donors, the vast majority of donors are deceased.

6 Feb 2013

Viracor-IBT Laboratories signs definitive agreement to purchase assets of Cylex

Viracor-IBT Laboratories, Inc. announced today that it has signed a definitive agreement to purchase the assets of Cylex, Inc., a global life sciences company focused on the development, manufacturing and commercialization of in vitro diagnostic products intended to illuminate immunity in the area of transplant medicine.

5 Feb 2013

Results from Merck’s Vorinostat phase 1 trial on lymphoma

Patients whose aggressive lymphomas have relapsed or failed to respond to the current front-line chemotherapy regimen now have an effective second line of attack against their disease.

5 Feb 2013

Orphan, St George's sign licensing agreement to develop new therapies for metabolic disorders

St George's, University of London has signed an exclusive worldwide licensing agreement with rare-disease research-and-development firm Orphan Technologies Ltd to develop new therapies for deadly metabolic disorders.

5 Feb 2013

Synageva announces 12-week data from sebelipase alfa Phase I/II study on LAL Deficiency

Synageva BioPharma Corp. (Synageva), a clinical stage biopharmaceutical company developing therapeutic products for rare diseases, today announced publication of the 12-week Phase I/II extension study data of sebelipase alfa in adults with lysosomal acid lipase deficiency (LAL Deficiency) in the online version and an upcoming print edition of Hepatology

5 Feb 2013

Seattle Genetics receives Health Canada approval for ADCETRIS to treat sALCL, Hodgkin lymphoma

Seattle Genetics, Inc. today announced that Health Canada has issued a Notice of Compliance with conditions (NOC/c), authorizing marketing of ADCETRIS for two lymphoma indications.

1 Feb 2013

Notch protein responsible for activating GATA2 gene to generate hematopoietic stem cells

Researchers from the group on stem cells and cancer at IMIM (Hospital del Mar Medical Research Institute) have deciphered one of the gene regulation circuits which would make it possible to generate hematopoietic blood cells, i.e. blood tissue stem cells.

1 Feb 2013

Family history one of the strongest predictors of heart disease

Sherron Simmons lived her life as the picture of good health: she exercised regularly, ate healthy and did not smoke. That is why it was a shock for her to learn in 2007 that the main left artery to her heart was 90 percent blocked.

1 Feb 2013

EUROSTAM, AbSorber receive 2.6M grant as part of European Commission FP7

Allenex announces that Allenex group company AbSorber, together with EUROSTAM, a consortium of European Transplant Centers, has been supported by a € 2.6 million grant as part of the European Commission 7th framework programme (FP7).

1 Feb 2013

African-Americans without private health insurance less likely to receive kidney transplants

African-Americans and individuals without private health insurance are less likely than others to receive a kidney transplant before requiring dialysis, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society of Nephrology (CJASN).

1 Feb 2013

Delaware District Court rules in favor of Pfizer in RAPAMUNE patent case

Pfizer Inc. said today that the United States District Court for the District of Delaware ruled that Pfizer's patent covering a method for using sirolimus, the active ingredient in RAPAMUNE®, for the inhibition of organ transplant rejection is valid and infringed.

31 Jan 2013

Left ventricular assist device improves quality of life in two brothers with Becker's Muscular Dystrophy

Tyler Wertz, 18, and his 16-year old brother Austin Tucker, fight, tease, love and support each other like most brothers do. Unlike most brothers, however, they share the same uncertain future—both have heart assist devices keeping them alive while they struggle with a debilitating disease. As young boys, Tyler and Austin were diagnosed with Becker's Muscular Dystrophy, a disease that slowly weakens the arms and legs and damages the heart.

31 Jan 2013

UIC to determine whether exercise can shorten recovery time for stem cell transplant patients

Researchers at the University of Illinois at Chicago College of Nursing have received a four-year grant to determine whether exercise can shorten recovery time for patients who undergo high-dose chemotherapy and stem cell transplantation.

From Danaher 31 Jan 2013

HIV-positive patients have higher incidence of non-melanoma skin cancers

HIV-positive patients have a higher incidence of non-melanoma skin cancers, according to a Kaiser Permanente study that appears in the current online issue of the Journal of the National Cancer Institute. Specifically, basal cell and squamous cell carcinomas occur more than twice as often among HIV-positive individuals compared to those who are HIV-negative.

30 Jan 2013

Double transplants can be successful with donor lungs from heavy smokers

Lungs from carefully selected donors with a heavy smoking history can be used with good results in adult, double-lung transplants, according to a study released today at the 49th Annual Meeting of The Society of Thoracic Surgeons held at the Los Angeles Convention Center.

29 Jan 2013

Minimally invasive islet transplantation reverses progression of atherosclerosis in type 1 diabetics

Minimally invasive islet transplantation for patients with type 1 diabetes achieves insulin independence and reverses the progression of atherosclerosis in the first few years after transplant, according to a University of Illinois at Chicago study.

29 Jan 2013

Daily antibacterial baths can safely reduce risk of bloodstream infections in critically ill children

Daily baths with an ordinary antibacterial cleanser can safely reduce the risk of dangerous bloodstream infections in critically ill children, according to a trial conducted in five pediatric hospitals and led by investigators at the Johns Hopkins Children's Center.

28 Jan 2013

Millennium, Seattle Genetics commence ADCETRIS plus chemotherapy phase III trial in MTCL

Seattle Genetics, Inc. and Millennium: The Takeda Oncology Company, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited (TSE:4502), today announced the initiation of a global phase III clinical trial evaluating ADCETRIS (brentuximab vedotin) in combination with chemotherapy for the treatment of newly diagnosed CD30-positive mature T-cell lymphoma (MTCL) patients, including patients with systemic anaplastic large cell lymphoma (sALCL) and other types of peripheral T-cell lymphomas.

28 Jan 2013

Periodontal health influences stem cell transplant success

Periodontal infection can increase the risk for developing bacteremia during the neutropenic phase of allogeneic hematopoietic stem cell transplantation, research suggests.

25 Jan 2013

Transplant News and Research

Burkitt lymphoma risk after transplantation highlighted

Donor liver quality: an interview with Dr Eric Orman

Viracor-IBT Laboratories signs definitive agreement to purchase assets of Cylex

Results from Merck’s Vorinostat phase 1 trial on lymphoma

Orphan, St George's sign licensing agreement to develop new therapies for metabolic disorders

Synageva announces 12-week data from sebelipase alfa Phase I/II study on LAL Deficiency

Seattle Genetics receives Health Canada approval for ADCETRIS to treat sALCL, Hodgkin lymphoma

Notch protein responsible for activating GATA2 gene to generate hematopoietic stem cells

Family history one of the strongest predictors of heart disease

EUROSTAM, AbSorber receive 2.6M grant as part of European Commission FP7

African-Americans without private health insurance less likely to receive kidney transplants

Delaware District Court rules in favor of Pfizer in RAPAMUNE patent case

Left ventricular assist device improves quality of life in two brothers with Becker's Muscular Dystrophy

UIC to determine whether exercise can shorten recovery time for stem cell transplant patients

HIV-positive patients have higher incidence of non-melanoma skin cancers

Double transplants can be successful with donor lungs from heavy smokers

Minimally invasive islet transplantation reverses progression of atherosclerosis in type 1 diabetics

Daily antibacterial baths can safely reduce risk of bloodstream infections in critically ill children

Millennium, Seattle Genetics commence ADCETRIS plus chemotherapy phase III trial in MTCL

Periodontal health influences stem cell transplant success

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest News